Carin
Carin Borgvall, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20110160435 | PROCESS OF PURIFYING COAGULATION FACTOR VIII - A process of purifying or enriching coagulation FVIII employing chromatography comprising the steps of providing a fraction containing FVIII in an aqueous solution having a high ionic strength; contacting the fraction containing FVIII with a multimodal resin; optionally washing the multimodal resin having FVIII adsorbed with an aqueous washing buffer; eluting FVIII containing fractions by an aqueous elution buffer comprising at least one amino acid which is positively charged at pH 6 to 8; and optionally collecting FVIII containing fractions in purified or enriched form. | 06-30-2011 |
Carin Johansson Seechurn, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20130165660 | COMPLEXES - A complex of formula (1), | 06-27-2013 |
Carin Malmborg, Hoor SE
Patent application number | Description | Published |
---|---|---|
20150273131 | PHOSPHATE AND UREA ADSORPTION FOR DIALYSIS | 10-01-2015 |
Carin Vorde, Karlskoga SE
Patent application number | Description | Published |
---|---|---|
20080226533 | Method of Producing Salts of Dinitramidic Acid - A method of preparing salt of dinitramidic acid, comprising nitration of an initial compound with a nitrating acid mixture to form dinitramidic acid in a reaction mixture. A positive ion is added to the reaction mixture and forms with the dinitramide ion an ion pair complex which precipitates in the acidic reaction mixture, and the precipitate is separated from the mixture. The remaining spent acid can be reprocessed for recovery of acid for preparation of a new nitrating acid mixture. The preferred positive ion is the guanylurea ion which gives a precipitate of guanylurea dinitramide. The precipitate can be used as starting material for preparation of other dinitramide salts, such as KDN and ADN. The guanylurea ion can be formed in situ in the process by cyanoguanidine being reacted with the reaction mixture. | 09-18-2008 |
Carin Vörde, Karlskoga SE
Patent application number | Description | Published |
---|---|---|
20120272854 | METHOD FOR COMBATING EXPLOSIVE-CHARGED WEAPON UNITS, AND PROJECTILE DESIGNED FOR THE SAME - The invention relates to a method of with a projectile ( | 11-01-2012 |
Carin WinderstrÖm, Hollviken SE
Patent application number | Description | Published |
---|---|---|
20100286603 | KIT AND METHOD FOR PREPARATION OF A DEGARELIX SOLUTION - A kit and method for preparing a Degarelix solution for administration to a patient. The kit includes a first chamber containing lyophilised Degarelix, a second chamber containing water, a syringe for transferring the water from the first chamber to the second chamber, at least one of a hypodermic needle, a safety needle device, or a needleless device for delivery of the Degarelix to the patient, and a mixing apparatus. The mixing apparatus is configured to receive the first chamber to mix the Degarelix and water to produce a Degarelix solution suitable for deliver to a patient. The method includes transferring a volume of water from a first chamber into a second chamber containing lyophilised Degarelix, connecting the second chamber to a mixing apparatus and mixing the water and lyophilised Degarelix for a period of time. | 11-11-2010 |
Carin WinderstrÖm, Hollviken SE
Patent application number | Description | Published |
---|---|---|
20100286603 | KIT AND METHOD FOR PREPARATION OF A DEGARELIX SOLUTION - A kit and method for preparing a Degarelix solution for administration to a patient. The kit includes a first chamber containing lyophilised Degarelix, a second chamber containing water, a syringe for transferring the water from the first chamber to the second chamber, at least one of a hypodermic needle, a safety needle device, or a needleless device for delivery of the Degarelix to the patient, and a mixing apparatus. The mixing apparatus is configured to receive the first chamber to mix the Degarelix and water to produce a Degarelix solution suitable for deliver to a patient. The method includes transferring a volume of water from a first chamber into a second chamber containing lyophilised Degarelix, connecting the second chamber to a mixing apparatus and mixing the water and lyophilised Degarelix for a period of time. | 11-11-2010 |